FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

108825009: Dexrazoxane (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173359010 Dexrazoxane en Synonym Active Entire term case insensitive SNOMED CT core module
605119015 Dexrazoxane (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dexrazoxane Is a Cytoprotective agent false Inferred relationship Existential restriction modifier
Dexrazoxane Is a Medicinal product acting as antidote agent (product) false Inferred relationship Existential restriction modifier
Dexrazoxane Is a Cytoprotective agent false Inferred relationship Existential restriction modifier
Dexrazoxane Is a Antidote true Inferred relationship Existential restriction modifier
Dexrazoxane Is a Piperazine derivative true Inferred relationship Existential restriction modifier
Dexrazoxane Is a Antineoplastic agent true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Dexrazoxane hydrochloride 250mg/vial powder Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane hydrochloride 500mg/vial powder Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane hydrochloride Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Product containing dexrazoxane Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier 1
Dexrazoxane hydrochloride Is a False Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane hydrochloride Is modification of True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier 1
Product containing dexrazoxane in parenteral dose form (medicinal product form) Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier 1
Product containing only dexrazoxane in parenteral dose form (medicinal product form) Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier 1
Product containing precisely dexrazoxane (as dexrazoxane hydrochloride) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Dexrazoxane Inferred relationship Existential restriction modifier 1
Dexrazoxane 500mg powder and solvent for solution for injection vials Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Savene 500mg powder and solvent for solution for injection vials (TopoTarget A/S) Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder and solvent for solution for injection vials 10 vial Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Savene 500mg powder and solvent for solution for injection vials (TopoTarget A/S) 10 vial Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder for solution for injection vials Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Cardioxane 500mg powder for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder for solution for injection vials 1 vial Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Cardioxane 500mg powder for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has active ingredient False Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder and solvent for solution for injection vials 10 vial Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder and solvent for solution for injection vials Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Savene 500mg powder and solvent for solution for injection vials (TopoTarget A/S) 10 vial Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Savene 500mg powder and solvent for solution for injection vials (TopoTarget A/S) Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder for solution for injection vials Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Cardioxane 500mg powder for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Dexrazoxane 500mg powder for solution for injection vials 1 vial Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier
Cardioxane 500mg powder for solution for infusion vials (Novartis Pharmaceuticals UK Ltd) 1 vial Has specific active ingredient True Dexrazoxane Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start